1. Zhan, Chaoning, Huang, Minchun, Yang, Xiaojun, Hou, Jin. 2021. MLKL: Functions beyond serving as the Executioner of Necroptosis. In Theranostics, 11, 4759-4769. doi:10.7150/thno.54072. https://pubmed.ncbi.nlm.nih.gov/33754026/
2. Lawlor, Kate E, Murphy, James M, Vince, James E. . Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases. In Immunity, 57, 429-445. doi:10.1016/j.immuni.2024.02.011. https://pubmed.ncbi.nlm.nih.gov/38479360/
3. Geng, Lu, Gao, Wenqing, Saiyin, Hexige, Zhang, Zhuohua, Li, Jixi. 2023. MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson's disease. In Molecular neurodegeneration, 18, 94. doi:10.1186/s13024-023-00686-5. https://pubmed.ncbi.nlm.nih.gov/38041169/
4. Oduro, Patrick Kwabena, Zheng, Xianxian, Wei, Jinna, Du, Mei, Wang, Qilong. 2021. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. In Acta pharmaceutica Sinica. B, 12, 50-75. doi:10.1016/j.apsb.2021.05.011. https://pubmed.ncbi.nlm.nih.gov/35127372/
5. Foerster, Elisabeth G, Mukherjee, Tapas, Cabral-Fernandes, Liliane, Girardin, Stephen E, Philpott, Dana J. 2021. How autophagy controls the intestinal epithelial barrier. In Autophagy, 18, 86-103. doi:10.1080/15548627.2021.1909406. https://pubmed.ncbi.nlm.nih.gov/33906557/
6. Majdi, Amine, Aoudjehane, Lynda, Ratziu, Vlad, Housset, Chantal, Gautheron, Jérémie. 2019. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease. In Journal of hepatology, 72, 627-635. doi:10.1016/j.jhep.2019.11.008. https://pubmed.ncbi.nlm.nih.gov/31760070/
智鼠故事 
